Group One Trading’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.32M Sell
67,500
-8,400
-11% -$552K 0.01% 1548
2026
Q1
$5.4M Sell
75,900
-21,600
-22% -$1.7M 0.01% 1242
2025
Q4
$8M Buy
97,500
+10,700
+12% +$834K 0.01% 1103
2025
Q3
$6.52M Sell
86,800
-34,800
-29% -$2.6M 0.01% 1255
2025
Q2
$9.01M Buy
121,600
+33,600
+38% +$2.34M 0.02% 883
2025
Q1
$7.1M Buy
88,000
+37,800
+75% +$3.25M 0.02% 825
2024
Q4
$3.92M Buy
50,200
+42,900
+588% +$3.65M 0.01% 1337
2024
Q3
$685K Sell
7,300
-4,000
-35% -$336K ﹤0.01% 2621
2024
Q2
$880K Sell
11,300
-5,400
-32% -$440K ﹤0.01% 2094
2024
Q1
$1.52M Buy
16,700
+2,700
+19% +$225K 0.01% 1719
2023
Q4
$1.08M Buy
14,000
+7,400
+112% +$518K ﹤0.01% 2398
2023
Q3
$449K Sell
6,600
-100,000
-94% -$7.28M ﹤0.01% 3020
2023
Q2
$8.66M Buy
106,600
+12,400
+13% +$990K 0.03% 592
2023
Q1
$7.73M Buy
+94,200
New +$6.73M 0.03% 617

Other funds holding GEHC

Group One Trading's GEHC Position: Q2 2026 in Review

Group One Trading increased its GE HealthCare (GEHC) stake by 7.4% in Q2 2026, buying an estimated $39.2K and bringing the position to 8,647 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

Group One Trading first reported a position in GEHC in Q2 2023 and has held it in 6 quarters since. The position peaked at $2.03M in Q2 2025. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Group One Trading held 8,647 shares of GE HealthCare worth $553K as of Q2 2026.
  • Group One Trading bought 596 GE HealthCare shares in Q2 2026, an estimated $39.2K.
  • GE HealthCare made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3399 holding.
  • Group One Trading first reported a position in GE HealthCare in Q2 2023 and has held it in 6 quarters since.
  • Group One Trading's GE HealthCare position peaked at $2.03M in Q2 2025.
  • 1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.